Literature DB >> 26246109

Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.

Orlando Galego1, Ana Gouveia2, Sónia Batista2, Cristina Moura3, Egídio Machado3.   

Abstract

UNLABELLED: Grey matter atrophy has been shown in primary progressive multiple sclerosis (PPMS), but its association with physical incapacity is unclear. We submitted 19 patients with PPMS to a neurological evaluation and brain magnetic resonance imaging (MRI) with volumetric analysis using FreeSurfer. We found no relation between the Expanded Disability Status Scale or disease duration and the grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes, but not with total white matter volume. We concluded that physical disability in PPMS is not directly related to brain atrophy and that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration.
INTRODUCTION: Primary progressive multiple sclerosis (PPMS) is characterized by chronic progression since onset, with predominant involvement of the spinal cord and prominent neurodegeneration. Grey matter atrophy has been shown in patients with PPMS, but its association with clinical incapacity is uncertain. We investigated the relationship between regional brain atrophy and physical disability in patients with PPMS.
METHODS: Patients with an established diagnosis of PPMS underwent a neurological evaluation followed by brain MRI at 1.5 T. Volumetric analysis was performed with FreeSurfer software, and evaluated the neocortex, total white matter, total subcortical grey matter, putamen, caudate, globus pallidus, thalamus, hippocampus, brainstem, corpus callosum and pre-central gyrus volumes. Clinical data obtained included physical disability as measured by the Expanded Disability Status Scale (EDSS).
RESULTS: Nineteen patients were included, 14 female (73.7%), mean age of 55.7 (SD 7.6) and mean disease duration of 13.0 years (SD 8.8). Median EDSS score was 6.0 (3.5-8.0). The average T1 lesion load (4.9 cm³, SD 3.4) and T2 load (10.5 cm³, SD 9.9) did not relate to disease duration. There was no significant correlation between EDSS score or disease duration and the cortical grey matter, deep grey matter or white matter structures analysed. Lesion load was negatively correlated with cortical and subcortical grey matter volumes (p < 0.05), but not with total white matter volume.
CONCLUSIONS: Physical disability in PPMS is not directly related to brain volume loss. Grey matter atrophy correlates with lesion load in patients with PPMS, indicating that focal inflammatory white matter lesions may contribute to progressive neuronal degeneration.
© The Author(s) 2015.

Entities:  

Keywords:  FreeSurfer; MRI; Primary progressive multiple sclerosis; grey matter atrophy

Mesh:

Year:  2015        PMID: 26246109      PMCID: PMC4757290          DOI: 10.1177/1971400915594984

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  40 in total

1.  Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.

Authors:  Marco Battaglini; Antonio Giorgio; Maria L Stromillo; Maria L Bartolozzi; Leonello Guidi; Antonio Federico; Nicola De Stefano
Journal:  J Neurol Sci       Date:  2009-03-16       Impact factor: 3.181

2.  Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.

Authors:  Benedetta Bodini; Zhaleh Khaleeli; Mara Cercignani; David H Miller; Alan J Thompson; Olga Ciccarelli
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 3.  The role of magnetic resonance imaging in the study of multiple sclerosis: diagnosis, prognosis and understanding disease pathophysiology.

Authors:  Massimo Filippi; Maria A Rocca
Journal:  Acta Neurol Belg       Date:  2011-06       Impact factor: 2.396

4.  Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

Authors:  Raju Kapoor; Julian Furby; Thomas Hayton; Kenneth J Smith; Daniel R Altmann; Robert Brenner; Jeremy Chataway; Richard A C Hughes; David H Miller
Journal:  Lancet Neurol       Date:  2010-06-08       Impact factor: 44.182

Review 5.  Cognition in multiple sclerosis: relevance of lesions, brain atrophy and proton MR spectroscopy.

Authors:  Antonio Giorgio; Nicola De Stefano
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

6.  Gray matter atrophy in multiple sclerosis: a longitudinal study.

Authors:  Elizabeth Fisher; Jar-Chi Lee; Kunio Nakamura; Richard A Rudick
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

7.  Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.

Authors:  M P Amato; E Portaccio; M L Stromillo; B Goretti; V Zipoli; G Siracusa; M Battaglini; A Giorgio; M L Bartolozzi; L Guidi; S Sorbi; A Federico; N De Stefano
Journal:  Neurology       Date:  2008-08-26       Impact factor: 9.910

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis.

Authors:  V M Anderson; C A M Wheeler-Kingshott; K Abdel-Aziz; D H Miller; A Toosy; A J Thompson; O Ciccarelli
Journal:  Mult Scler       Date:  2011-04-20       Impact factor: 6.312

10.  Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability.

Authors:  Z Khaleeli; M Cercignani; B Audoin; O Ciccarelli; D H Miller; A J Thompson
Journal:  Neuroimage       Date:  2007-05-18       Impact factor: 6.556

View more
  4 in total

1.  T1 Recovery Is Predominantly Found in Black Holes and Is Associated with Clinical Improvement in Patients with Multiple Sclerosis.

Authors:  C Thaler; T D Faizy; J Sedlacik; B Holst; K Stürner; C Heesen; J-P Stellmann; J Fiehler; S Siemonsen
Journal:  AJNR Am J Neuroradiol       Date:  2016-11-10       Impact factor: 3.825

2.  Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis.

Authors:  A Burgetova; P Dusek; M Vaneckova; D Horakova; C Langkammer; J Krasensky; L Sobisek; P Matras; M Masek; Z Seidl
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

Review 3.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

4.  Gray Matter Matters: A Longitudinal Magnetic Resonance Voxel-Based Morphometry Study of Primary Progressive Multiple Sclerosis.

Authors:  Ted L Rothstein
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.